Upstream Bio to Present at Upcoming March Investor Conferences

Rhea-AI Summary

Upstream Bio (Nasdaq: UPB), a clinical-stage company focused on developing treatments for inflammatory diseases with an emphasis on severe respiratory disorders, has announced its participation in two major investor conferences in March 2025.

CEO Rand Sutherland, MD, will present at the TD Cowen 45th Annual Health Care Conference in Boston, MA on Tuesday, March 4, 2025, from 11:50 a.m. to 12:20 p.m. ET. He will also present at the Leerink Partners Global Biopharma Conference 2025 in Miami, FL on Wednesday, March 12, 2025, from 1:40 p.m. to 2:10 p.m. ET.

Interested parties can access a live webcast of the presentations under the "Events" tab on the "Investors" page of the company's website on the day of each event. Replays of the webcasts will be available on the company's website following the presentations.

Positive

• Upstream Bio is actively engaging with investors through participation in two major healthcare conferences
• The company's CEO will personally present, indicating high-level commitment to investor relations
• Providing live webcasts shows transparency and accessibility for all investors
• The company is maintaining visibility in the investment community while developing treatments for inflammatory diseases

Negative

• No specific updates on clinical progress or pipeline developments were mentioned in the announcement
• The press release doesn't include any financial information or business updates
• No mention of any new partnerships or collaborations
• The announcement is purely about investor conferences without substantive business news

WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio’s CEO, will present at the following upcoming March investor conferences:

• TD Cowen 45th Annual Health Care Conference, Boston MA
  Tuesday, March 4, 2025, 11:50 a.m. – 12:20 p.m. ET

• Leerink Partners Global Biopharma Conference 2025, Miami FL
  Wednesday, March 12, 2025, 1:40 p.m. – 2:10 p.m. ET

A live webcast of the presentation will be available under the “Events” tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be posted on the Company's website following the presentation.

About Upstream Bio

Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in clinical development that targets the receptor for thymic stromal lymphopoietin, a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. The Company has advanced this highly potent monoclonal antibody into separate Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. Upstream Bio’s team is committed to maximizing verekitug’s unique attributes to address the substantial unmet needs for patients underserved by today’s standard of care. To learn more, please visit www.upstreambio.com.

Investor Contact:
Michael Gray
Chief Financial Officer and Chief Operating Officer
ir@upstreambio.com

Media Contact:
Teri Dahlman
Red House Communications
teri@redhousecomms.com

FAQ

When will Upstream Bio (UPB) present at the TD Cowen Health Care Conference in March 2025?

Upstream Bio will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, March 4, 2025, from 11:50 a.m. to 12:20 p.m. ET.

What time is Upstream Bio's presentation at the Leerink Partners Global Biopharma Conference 2025?

Upstream Bio will present at the Leerink Partners Global Biopharma Conference in Miami on Wednesday, March 12, 2025, from 1:40 p.m. to 2:10 p.m. ET.

How can investors access Upstream Bio's (UPB) March 2025 conference presentations?

Investors can access a live webcast of the presentations under the "Events" tab on the "Investors" page of Upstream Bio's website on the day of each event. Replays will also be available on the website following the presentations.

What therapeutic areas is Upstream Bio (UPB) focusing on according to their March 2025 investor conference announcement?

According to the announcement, Upstream Bio is developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders.

Who will be representing Upstream Bio (UPB) at the March 2025 investor conferences?

Rand Sutherland, MD, who serves as Upstream Bio's CEO, will be presenting at both March 2025 investor conferences.

Which investor conferences will Upstream Bio (UPB) attend in March 2025?

Upstream Bio will attend two investor conferences in March 2025: the TD Cowen 45th Annual Health Care Conference in Boston on March 4, and the Leerink Partners Global Biopharma Conference in Miami on March 12.